Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong

Prenatal Diagnosis

Volumn 18, Issue 6, 1998, Pages 585-589

  Lam, Yung Hang ^a,c   Ghosh, Arabinda ^a   Tang, Mary Hoi Yin ^a   Tang, Lawrence Chang Hung ^b   Lee, Chin Peng ^a   Sin, Sai Yuen ^b   Ho, Philip Kin Hoi ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b KWONG WAH HOSPITAL   (Hong Kong)

^c TSAN YUK HOSPITAL   (Hong Kong)

Author keywords

Chinese; Down's syndrome; Screening; Second trimester

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AMNIOCENTESIS; ARTICLE; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; GONADOTROPIN BLOOD LEVEL; HONG KONG; HUMAN; HUMAN EXPERIMENT; MATERNAL AGE; NORMAL HUMAN; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; FALSE NEGATIVE REACTIONS; FEMALE; GESTATIONAL AGE; HONG KONG; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 0031778653     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199806)18:6<585::AID-PD305>3.0.CO;2-R     Document Type: Article

References (17)

1. Crossley, J.A., Aitken, D.A., Berry, E., Connor, J.M. (1994). Impact of a regional screening programme using maternal serum α-fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland, J. Med. Screen., 1, 180-183.
2. Cuckle, H.S. (1992). Measuring unconjugated estriol in maternal serum to screen for fetal Down syndrome, Clin. Chem., 38, 1687-1689.
3. Goodburn, S.F., Yates, J.R.W., Raggat, P.R., Carr, C., Ferguson-Smith, M.E., Kershaw, A.J., Milton, P.J.D., Ferguson-Smith, M.A. (1994). Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin and unconjugated oestriol: experience of a regional programme, Prenat. Diagn., 14, 391-402.
4. Haddow, J.E., Palomaki, G.E., Knight, G.J., Williams, J., Pukkinen, A., Canick, J.A., Saller, D. N. Jr, Bowers, G.B. (1992). Prenatal screening for Down's syndrome with use of maternal serum markers, N. Engl. J. Med., 327, 588-593.
5. Haddow, J.E., Palomaki, G.E. (1996). Similarities in women's decision-making in the U.S. and U.K. during prenatal screening for Down's syndrome, Prenat. Diagn., 16, 1161-1162.
6. Hsu, J.J., Hsieh, T.T., Hsieh, F.J. (1996). Down syndrome screening in an Asian population using alpha-fetoprotein and free β-hCG: a report of the Taiwan Down Syndrome Screening Groups, Obstet. Gynecol., 87, 943-947.
7. Macri, J.N., Ramana, V., Kasturi, B.E. (1990). Maternal serum Down syndrome screening: unconjugated estriol is not useful, Am. J. Obstet. Gynecol., 162, 672-673.
8. Macri, J.N., Spencer, K., Garver, K., Buchanan, P.D., Say, B., Carpenter, N.J., Muller, F., Boue, A. (1994). Maternal serum free beta hCG screening: results of studies including 480 cases of Down's syndrome, Prenat. Diagn., 14, 97-103.
9. Mooney, R.A., Peterson, J., French, C.A., Saller, D.N., Arvan, D.A. (1994). Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome, Obstet. Gynecol., 84, 298-303.
10. Muller, F., Bussieres, L., Pelissier, M.C., Oury, J.F., Boue, C., Uzan, S., Boue, A. (1994). Do racial differences exist in second-trimester maternal levels? A study of 23 369 patients, Prenat. Diagn., 14, 633-636.
11. Onda, T., Kitagawa, M., Takeda, O., Sago, H., Kubonoya, K., Iinuma, K., Bradley, L.A., Canick, J.A., Krasikov, N.E., Ponting, N.R., Grier, R.E. (1996). Triple marker screening in native Japanese women, Prenat. Diagn., 16, 713-717.
12. Palomaki, G.E., Neveux, L.M., Haddow, J.E. (1996). Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?, J. Med. Screen., 3, 12-17.
13. Phillips, O.P., Elias, S., Shulman, L.P., Anderson, R.N., Morgan, C.D., Simpson, J.L. (1992). Maternal serum screening for fetal Down's syndrome in women less than 35 years of age using alpha-fetoprotein, hCG and unconjugated estriol: a prospective 2-year study, Obstet. Gynecol., 80, 353-358.
14. Reynolds, T., John, R. (1992). Comparison of assay kits for unconjugated estriol shows that expressing results as multiples of the median causes unacceptable variation in calculated risk factors for Down syndrome, Clin. Chem., 38, 1888-1893.
15. Spencer, K. (1994). Is the measurement of unconjugated estriol of value in screening for Down's syndrome. In: Grudzinskas, J.G., Chard, T., Chapman, M., Cuckle, H. (Eds). Screening for Down's Syndrome, Cambridge: Cambridge Press, 141-161.
16. Wald, N.J., Cuckle, H.S., Densem, J.W., Nanchahal, K., Royston, R., Chard, T., Haddow, J.E., Knight, G.J., Palomaki, G.E., Canick, J.A. (1988). Maternal serum screening for Down's syndrome in early pregnancy, Br. Med. J., 297, 883-887.
17. Wald, N.J., Kennard, A., Densem, J.W., Cuckle, H.S., Chard, T., Butler, L. (1992). Antenatal maternal serum screening for Down's syndrome: results of a demonstration project, Br. Med. J., 305, 391-394.